WELLS FARGO & COMPANY/MN - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$178,036
-64.1%
17,285
-42.6%
0.00%
Q2 2023$496,048
+249.4%
30,100
+94.2%
0.00%
Q1 2023$141,980
+133.3%
15,500
+82.4%
0.00%
Q4 2022$60,860
+4.9%
8,500
-26.1%
0.00%
Q3 2022$58,000
+107.1%
11,505
-0.8%
0.00%
Q2 2022$28,000
-61.1%
11,600
+9.4%
0.00%
Q1 2022$72,000
-90.3%
10,600
-88.5%
0.00%
Q4 2021$743,000
-52.3%
91,950
-42.2%
0.00%
Q3 2021$1,558,000
+7.7%
159,000
-26.0%
0.00%
Q2 2021$1,447,000
-24.5%
214,950
+1.4%
0.00%
Q1 2021$1,916,000
+1082.7%
212,000
+773.5%
0.00%
Q4 2020$162,000
+276.7%
24,269
+183.5%
0.00%
Q3 2020$43,000
-21.8%
8,559
+26.8%
0.00%
Q2 2020$55,000
+223.5%
6,750
+223.1%
0.00%
Q1 2020$17,000
-43.3%
2,089
-47.8%
0.00%
Q4 2019$30,000
+500.0%
4,000
+255.6%
0.00%
Q3 2019$5,000
+66.7%
1,125
+12.5%
0.00%
Q2 2019$3,000
+200.0%
1,0000.0%0.00%
Q1 2019$1,000
-66.7%
1,000
-0.1%
0.00%
Q4 2018$3,000
-75.0%
1,001
-64.3%
0.00%
Q3 2018$12,000
-45.5%
2,801
-20.7%
0.00%
Q2 2018$22,000
+10.0%
3,532
+29.3%
0.00%
Q1 2018$20,000
-4.8%
2,732
+8.8%
0.00%
Q4 2017$21,000
+31.2%
2,511
+66.2%
0.00%
Q3 2017$16,000
+45.5%
1,511
+51.1%
0.00%
Q2 2017$11,0000.0%1,000
-6.7%
0.00%
Q1 2017$11,0001,0720.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders